Provide Our New Breast Unit with Three New Mammography Machines Using Tomosynthesis Technology

Provide Our New Breast Unit with Three New Mammography Machines Using Tomosynthesis Technology

News Release
Date: 03 November 2016 / Ref: 050/2016
From the Royal to the rainforest

A team of Royal trekkers have completed a 9-day expedition through one of the world’s largest rainforests to raise vital funds for R Charity.
Royal Liverpool University and Broadgreen Hospitals NHS Trust chief executive Aidan Kehoe, deputy medical director Dr Julian Hobbs and specialist pharmacist Laura Perry all completed the gruelling 25-mile challenge through Borneo’s rainforest to help raise funds for the new Royal Liverpool University Hospital.
The fundraising challenge, which looks set to raise an impressive £6500, also included climbing the 13,435ft Mount Kinabalu – South-East Asia’s highest peak.
Pharmacist Laura Parry enjoyed swapping walking the Royal’s corridors for trekking through the humid 130million-year-old rainforest for R Charity.
Laura Perry said: “The opportunity to trek through the amazing Crocker Range National Park as well as climbing Mount Kinabalu was fantastic!
“The challenge definitely took me out of my comfort zone but the experience, the spectacular views and the personal reward was incredible and raising money for R Charity made all the tough moments worthwhile.”
Funds raised from the trek will help to buy the latest treatments, technologies and patient comforts in the new Royal.
Deputy medical director Dr Julian Hobbs said: “The trek was a fantastic and extremely challenging experience and a great way to raise money for our appeal for the new Royal Liverpool University Hospital. I will always remember reaching the summit of Mount Kinabalu in time to see the sun rise over the rainforest.”
Aidan Kehoe, chief executive, added: “We want to give the people of Merseyside access to the best possible treatment and technology and deliver a hospital the city can be proud of. Money raised will help us to buy the most advanced technologies and patient comforts, enabling us to achieve our ambition of providing the world class hospital our staff and patients need.”
To find out how you can support R Charity visit or call 0151 706 3153
Ends
Notes to Editors:
Photo one: Chief executive Aidan Kehoe (left), specialist pharmacist Laura Perry (centre), deputy medical director Dr Julian Hobbs (right)
Photo two: Laura Perry climbing Mount Kinabalu
Photo three: Laura climbing Mount Kinabalu
Photo four: The trekkers make their way through the Borneo rainforest
About R Charity
R Charity’s £10 Million Appeal will enable the Royal to embrace the latest surgical and technological developments, to give the best treatments and support possible to those who require eye treatment.
We will also invest care and over £100,000 to ensure that getting stroke patients out of bed and back home to live a normal life as soon as is possible is at the heart of all that we do.
The appeal will fund a new telemetry monitoring system allowing us to improve patient safety and search for the causes of stroke, plus a suite of new specialist chairs which help severely disabled stroke patients sit out of bed and make the first steps towards recovery.
R Charity’s £10million target will enable us to:
  • Provide our new Breast Unit with three new mammography machines using tomosynthesis technology – a first for the region - so that we can see more patients sooner.
  • Provide 646 comfortable reclining chairs for patient bedrooms so that relatives can stay overnight to spend precious moments with their loved ones.
  • Provide smart TV screens for each of the 646 inpatient bedrooms so that patients can access Freeview TV at no cost. Friends and family will be able to bring in comforting photos of family life to view on screen - a huge benefit for confused, vulnerable patients.
  • Support the delivery of the very latest technologies for diagnosing cancer, stroke and bone conditions earlier and treating the disease more effectively. The new Royal will also be the regional centre of excellence for producing radioactive injections for use in our new scanners and treatments for cancers.